Refine by
Drug Designation Articles & Analysis
256 news found
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. These diagnostic services are designed to support the scientific community in identifying, understanding, and ...
In the ever-evolving landscape of pharmaceutical research and development, the demand for innovative and efficient drug discovery methods is more pressing than ever. At the forefront of this demanding field is Protheragen-ING AI-Pharma, a contract research and development biotechnology company, offering cutting-edge solutions to researchers through its AI-powered ...
Among the various materials used in medical device design, polytetrafluoroethylene (PTFE tubing) has emerged as a standout choice, particularly in applications such as catheters and drug delivery systems. ...
Unfortunately, existing drug formulations for glaucoma often have low bioavailability and inconsistent drug release rates. ...
CD ComputaBio, a pioneering provider of computational biology services, has recently introduced its advanced Computer-Aided Drug Design (CADD) services, revolutionizing the drug discovery landscape. ...
They’re widely used as drug carriers mainly because of their ability to efficiently carry and release drug molecules, thereby improving drug bioavailability and therapeutic efficacy. The design of such drug carriers also helps to overcome some of the limitations of conventional drugs such ...
In response to our positive initial data, the US Food and Drug Administration (FDA) awarded our HLHS program with three distinct and important designations: Rare Pediatric Disease designation, Orphan Drug designation, and Fast Track designation, each of which offer benefits to our development and ...
Controlled-release drug delivery systems are designed to release medications at a desired rate and duration, ensuring consistent therapeutic levels in the body. ...
One of the key areas of focus for CD Formulation is its Novel Drug Delivery System (NDDS) services. With a dedicated team of experts, the company offers an array of services aimed at designing and optimizing drug delivery systems. ...
These tiny, needle-like structures are designed to penetrate the outer layer of the skin, offering a range of benefits such as enhanced drug absorption, reduced side effects, and simplified self-administration. ...
In the realm of Antibody Drug Design Services, CD ComputaBio employs sophisticated computational methodologies to engineer antibodies of unparalleled precision and efficacy. ...
CD ComputaBio's Antibody De Novo Design technology aims to transform this landscape, offering a more efficient and cost-effective approach to drug development. ...
This approach is poised to revolutionize the field of drug discovery by offering researchers an efficient and cost-effective solution for identifying promising drug candidates. ...
Recently, the company introduced a series of state-of-the-art services in Drug Design and Computer-Aided Drug Design (CADD) with the aim of providing efficient and reliable solutions for the pharmaceutical industry's drug development endeavors. Drug Design is a crucial ...
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the launch of new reagent solutions for herpesvirus research, including a range of Human Herpesviruses Antibodies designed to help researchers better understand the structure of Herpesvirus entry and develop new treatments and prevention strategies. ...
The OCEANIC-AF (atrial fibrillation) study with asundexian is part of the Phase III OCEANIC clinical trial program enrolling more than 27,000 patients in over 40 countries Asundexian is being evaluated as a potential improved treatment option in stroke prevention and could be part of an entirely new class of treatment options in thrombosis management that aims to uncouple efficacy from ...
ByBayer AG
BOC Sciences, a leading CRO in the USA, unveils its comprehensive capabilities for custom peptide drug conjugate from project design to commercial production. With its well-established conjugation platform, BOC Sciences supports pharmaceutical and biotechnology clients at the forefront of drug conjugation. Peptide-drug conjugates ...
With customized delivery strategies, precise design and transformation of drugs/drug-loaded cargos, and advanced technology platforms, CD Bioparticles now offers a series of mRNA Transfection Reagents for researchers to assist the transfection of lipid vectors for mRNA into target cells. ...
The company is pleased to announce the launch of the Protein-Small Molecule Docking service, designed to help customers quickly and accurately design and screen drugs. ...
As a widely used and trusted molecular docking software, AutoDock simplifies molecular docking simulations and improves the accuracy of drug development. This software is widely used by researchers to simulate and predict the interaction between small molecules and the protein of interest, a fundamental technique for drug discovery and development. ...